Julianne Bruno

Julianne Bruno is Vice President and Head of Program Management at CRISPR Therapeutics. During her time at CRISPR, she’s held several different positions, including leading the hemoglobinopathy partnership program with Vertex through the early clinical stage through present day. In addition, Julianne is responsible for overseeing the immuno-oncology trials and program management function, which spans across all of the program areas (hemoglobinopathies, immune-oncology, regenerative medicine, in vivo) and partnerships. Before joining CRISPR, Julianne worked at McKinsey & Company where she was a leader in the biotech practice and served a number of biotechnology companies on a wide range of commercial topics. Julianne received her MBA from The Wharton School and also holds an A.B. from Princeton University.